TH171533A - ROR-Gamma-T methylene-linked quinolinyl modulator - Google Patents
ROR-Gamma-T methylene-linked quinolinyl modulatorInfo
- Publication number
- TH171533A TH171533A TH1501002063A TH1501002063A TH171533A TH 171533 A TH171533 A TH 171533A TH 1501002063 A TH1501002063 A TH 1501002063A TH 1501002063 A TH1501002063 A TH 1501002063A TH 171533 A TH171533 A TH 171533A
- Authority
- TH
- Thailand
- Prior art keywords
- formula
- ror
- disorders
- diseases
- symptoms
- Prior art date
Links
- 230000000051 modifying Effects 0.000 title claims abstract 3
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 title 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 title 1
- 201000010099 disease Diseases 0.000 claims abstract 8
- 150000001875 compounds Chemical class 0.000 claims abstract 5
- 239000000126 substance Substances 0.000 claims abstract 3
- 241000124008 Mammalia Species 0.000 claims abstract 2
- 206010039073 Rheumatoid arthritis Diseases 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims abstract 2
- 229940079593 drugs Drugs 0.000 claims abstract 2
- 230000000694 effects Effects 0.000 claims abstract 2
- 230000000116 mitigating Effects 0.000 claims abstract 2
- 201000004681 psoriasis Diseases 0.000 claims abstract 2
- 230000001225 therapeutic Effects 0.000 claims abstract 2
- 150000003839 salts Chemical class 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
Abstract
คำขอใหม่ปรับปรุง วันที่ 26/02/2559 การประดิษฐ์นี้ประกอบรวมด้วยสารประกอบที่มีสูตร (I) (สูตรเคมี) สูตร I โดยที่ R1,R2,R3,R4,R5,R6,R7,R8 และ R9 เป็นดังที่ระบุไว้ในข้อกำหนดเฉพาะ การประดิษฐ์นี้ยังประกอบรวมด้วยวิธีการในการรักษาหรือบรรเทาอาการ, ความผิดปกติ หรือโรค โดยที่อาการ, ความผิดปกติ หรือ โรคดังกล่าวเป็นโรคข้ออักเสบรูมาทอยด์และโรคสะเก็ดเงิน การ ประดิษฐ์นี้ยังประกอบรวมด้วยวิธีการในการมอดูเลตสภาพการออกฤทธิ์ ROR(สูตร)t ในสัตว์เลี้ยงลูกด้วยนม โดยการบริหารปริมาณที่มีประสิทธิผลในการบำบัดรักษาของสารประกอบตามข้อถือสิทธิ 1 อย่างน้อย หนึ่งชนิด: สิทธิบัตรยา New request updated 26/02/2016 This invention includes compounds with formula (I) (chemical formula), formula I, where R1, R2, R3, R4, R5, R6, R7, R8 and R9 are as follows. Specified in specific requirements. The invention also includes methods for treating or mitigating symptoms, disorders or diseases where symptoms, disorders or diseases are rheumatoid arthritis and psoriasis. By means of modulation, the effect of ROR (formula) t in mammals. By administering therapeutic effective doses of at least one claim compound: drug patents
Claims (1)
Publications (1)
Publication Number | Publication Date |
---|---|
TH171533A true TH171533A (en) | 2017-12-21 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1122272T1 (en) | 3-CYCLOHEXENYL AND CYCLOHEXYL SUBSTITUTED INDOLE AND INDAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF | |
CR20150472A (en) | USE OF PIRAZOLOPIRIMIDINE DERIVATIVES FOR THE TREATMENT OF PI3Kd-RELATED DISORDERS | |
EA201690223A1 (en) | FACTOR INHIBITORS IN THE COMPLEMENT BASED ON PIPERIDININILINDOL DERIVATIVES AND THEIR APPLICATION | |
EA201690044A1 (en) | NUCLEAR TRANSPORT MODULATORS AND THEIR APPLICATION | |
EA201592256A1 (en) | DERIVATIVES OF IMIDAZOPIRROLIDINONE AND THEIR APPLICATION IN THE TREATMENT OF DISEASES | |
EA201591727A1 (en) | BIARYLAMIDE COMPOUNDS AS KINASE INHIBITORS | |
PH12015500817B1 (en) | Methylene linked quinolinyl modulators of ror-gamma-t | |
EA201590200A1 (en) | MODULATORS OF THE COMPLEMENT ACTIVATION WAY AND THEIR APPLICATION | |
GT201500030A (en) | 1,4-DISPOSED PIRIDAZINE ANALOGS AND METHODS FOR THE TREATMENT OF CONDITIONS RELATED TO THE DEFICIENCY OF SMN | |
BR112015032921A8 (en) | substituted benzofuranyl and benzoxazolyl compounds and their uses | |
EA201690287A1 (en) | 1,4-DESIGNED ANALOGUES OF PYRIDAZIN QUINOLINE AND METHODS OF TREATING CONDITIONS ASSOCIATED WITH SMN-DEFICIENCY | |
BR112015016395A2 (en) | 3-substituted pyrazoles and use as dlk inhibitors | |
EA201691070A1 (en) | NEW TRICYCLIC CONNECTIONS AS ANTICATIVE AGENTS | |
PH12015500776A1 (en) | Phenyl linked quinolinyl modulators of ror-gamma-t | |
MA37400A1 (en) | Cyclil compounds are not heterogeneous as mek inhibitors | |
EA201592255A1 (en) | DERIVATIVES OF PYRAZOLOPIRROLIDIN-4-IT AS A BET INHIBITOR AND THEIR APPLICATION IN THE TREATMENT OF THE DISEASE | |
EA201690247A1 (en) | AMINOMETHYBYRIL DERIVATIVES-INHIBITORS OF COMPLEX D FACTOR AND USE | |
EA201492023A1 (en) | REGULATORS OF THE COMPLEX WAY AND THEIR APPLICATION | |
BR112016008258A2 (en) | quinolinyl ror? t modulators | |
EA201592254A1 (en) | DERIVATIVES OF Pyrazolopyrrolidin-4-IT and THEIR APPLICATION IN THE TREATMENT OF DISEASE | |
CU20170158A7 (en) | SUBSTITUTED DERIVATIVES OF 1-ARILNAFTIRIDINA-3-CARBOXAMIDAS AND ITS UTILITY IN THE TREATMENT OR PREVENTION OF CARDIOVASCULAR AND RENAL DISEASES | |
MY179605A (en) | Use of benzimidazole-proline derivatives | |
EA201591409A1 (en) | BICYCLIC COMPOUNDS | |
BR112016001928A2 (en) | piperidine derivatives urea | |
EA201600394A1 (en) | TRICYCLIC COMPOUNDS OF PIPERIDINE |